Our results have also shown that a slightly higher proportion (76% versus 63%) of Grade III tumour samples exhibited high PRMT7 expression when compared to the Grade I/II tumour group, although this trend did not reach statistical significance with our sample size. The gene discussed is PRMT7; the disease is neoplasm.